{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:24:06Z","timestamp":1792589046409,"version":"4.5.0"},"reference-count":38,"publisher":"Massachusetts Medical Society","issue":"8","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2024,8,22]]},"DOI":"10.1056\/nejmoa2313906","type":"journal-article","created":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T21:00:50Z","timestamp":1724274050000},"page":"710-721","source":"Crossref","is-referenced-by-count":205,"title":["Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma"],"prefix":"10.1056","volume":"391","author":[{"given":"Toni K.","family":"Choueiri","sequence":"first","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Powles","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katriina","family":"Peltola","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"de Velasco","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Burotto","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Suarez","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Ghatalia","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Iacovelli","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine T.","family":"Lam","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Verzoni","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"G\u00fcm\u00fc\u015f","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter M.","family":"Stadler","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Kollmannsberger","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohuslav","family":"Melichar","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Venugopal","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Gross-Goupil","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandr","family":"Poprach","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Santis","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio A.","family":"Schutz","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Hoon","family":"Park","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry A.","family":"Nosov","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo","family":"Porta","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Lyun","family":"Lee","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Garcia-del-Muro","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Biscaldi","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Manneh Kopp","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aobo","family":"Wang","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo F.","family":"Perini","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Vickery","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Albiges","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Rini","sequence":"additional","affiliation":[{"name":"From Dana\u2013Farber Cancer Institute, Boston (T.K.C.); Barts Cancer Centre, Queen Mary University of London BRC, Royal Free NHS Trust, London (T.P.), and Beatson West of Scotland Cancer Centre and the University of Glasgow, Glasgow (B.V.) \u2014 all in the United Kingdom; HUS Helsinki University Hospital, Comprehensive Cancer Center, Helsinki (K.P.); University Hospital 12 de Octubre, Instituto de Investigaci\u00f3n Sanitaria Hospital 12 de Octubre (imas12), Madrid (G.V.), and Medical Oncology, Vall d\u00b4Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d\u00b4Hebron, Vall d\u00b4Hebron Barcelona Hospital Campus (C.S.), and Institute Catalan of Oncology\u2013ICO-IDIBELL University of Barcelona (X.G.-M.), Barcelona \u2014 all in Spain; Bradford Hill Clinical Research Center, Santiago, Chile (M.B.); Fox Chase Cancer Center, Philadelphia (P.G.); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (R.I.), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (E.V.), the University of Bari \u201cA. Moro\u201d and Azienda Ospedaliera P..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz056"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.09.014"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1601333"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djaa064"},{"key":"e_1_3_5_6_2","unstructured":"National Comprehensive Cancer Network: NCCN guidelines insights: kidney cancer version 1.2021 (https:\/\/jnccn.org\/view\/journals\/jnccn\/18\/9\/article-p1160.xml?rskey=Cq3tP6=498=TrendMD=cpc=JNCCN_TrendMD_0=full%20html)."},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0164-0"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61613-9"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00290-9"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25219"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33033"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00543-4"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00922-4"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30735-1"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.08.007"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4921"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0209-1"},{"key":"e_1_3_5_18_2","first-page":"298","article-title":"The VHL tumor suppressor gene: insights into oxygen sensing and cancer.","volume":"128","author":"Kaelin WG","year":"2017","unstructured":"Kaelin WG Jr. The VHL tumor suppressor gene: insights into oxygen sensing and cancer. Trans Am Clin Climatol Assoc 2017;128:298-307.28790514","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.08.007"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1093-z"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000221"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103425"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01324-7"},{"key":"e_1_3_5_24_2","doi-asserted-by":"crossref","unstructured":"Agarwal N Brugarolas J Ghatalia P et al. Safety and efficacy of two doses of belzutifan in patients (pts) with advanced RCC: results of the randomized phase II LITESPARK-013 study. Ann Oncol 2023;34:Suppl 2:S1011-S1011. abstract (https:\/\/www.annalsofoncology.org\/article\/S0923-7534(23)01948-8\/fulltext).","DOI":"10.1016\/j.annonc.2023.09.1111"},{"key":"e_1_3_5_25_2","doi-asserted-by":"crossref","unstructured":"Choueiri TB Bauer T Merchan JR et al. Phase II LITESPARK-003 study of belzutifan in combination with cabozantinib for advanced clear cell renal cell carcinoma (ccRCC). Ann Oncol 2023;34:Suppl 2:S1328-S1329. abstract (https:\/\/www.annalsofoncology.org\/article\/S0923-7534(23)04233-3\/fulltext).","DOI":"10.1016\/j.annonc.2023.10.089"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035716"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026982"},{"key":"e_1_3_5_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1712126"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816714"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-00455-z"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000477"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113205"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2010.03.022"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2019.09.008"},{"key":"e_1_3_5_35_2","doi-asserted-by":"crossref","unstructured":"Maughan BL Srinivasan R Iliopoulos O et al. Effect of erythropoietin-stimulating agent use on belzutifan antitumor activity in patients with VHL disease\u2013associated renal cell carcinoma: post hoc analysis of the LITESPARK-004 study. J Clin Oncol 2024;42:Suppl:3-3. abstract (https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2024.42.4_suppl.3).","DOI":"10.1200\/JCO.2024.42.4_suppl.3"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0061"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510016"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510665"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.0253"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2313906","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:40:03Z","timestamp":1749667203000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2313906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,22]]}},"alternative-id":["10.1056\/NEJMoa2313906"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2313906","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}